Corcept Therapeutics Announces Fourth Quarter and Full-Year 2021 Audited Financial Results and Provides Corporate Update
February 15, 2022 16:05 ET
|
Corcept Therapeutics Incorporated
MENLO PARK, Calif., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial stage company engaged in the discovery, development and sale of drugs to treat...
Corcept Therapeutics to Announce Fourth Quarter and Full-year 2021 Financial Results, Provide Corporate Update and Host Conference Call
February 08, 2022 16:05 ET
|
Corcept Therapeutics Incorporated
MENLO PARK, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report fourth quarter and full-year 2021 financial results and provide...
Corcept Therapeutics Announces Final Results of Previously Announced Tender Offer
December 20, 2021 16:05 ET
|
Corcept Therapeutics Incorporated
MENLO PARK, Calif., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) (“Corcept”), a commercial-stage company engaged in the discovery and development of drugs to...
Corcept Therapeutics Announces Preliminary Results of Previously Announced Tender Offer
December 16, 2021 08:00 ET
|
Corcept Therapeutics Incorporated
MENLO PARK, Calif., Dec. 16, 2021 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) (“Corcept”), a commercial-stage company engaged in the discovery and development of drugs to...
Corcept Therapeutics Announces Waiver of Condition to its Tender Offer for Common Shares
December 15, 2021 08:00 ET
|
Corcept Therapeutics Incorporated
MENLO PARK, Calif., Dec. 15, 2021 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) (“Corcept”), a commercial-stage company engaged in the discovery and development of drugs to...
Corcept Therapeutics Announces Extension of Previously Announced Tender Offer
December 08, 2021 08:00 ET
|
Corcept Therapeutics Incorporated
MENLO PARK, Calif., Dec. 08, 2021 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) (“Corcept”) a commercial-stage company engaged in the discovery and development of drugs to...
Corcept Therapeutics to Present at Upcoming Investor Conferences
November 10, 2021 08:30 ET
|
Corcept Therapeutics Incorporated
MENLO PARK, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe...
Corcept Therapeutics Announces Commencement of Tender Offer to Purchase up to 10 Million Shares of its Common Stock
November 08, 2021 08:30 ET
|
Corcept Therapeutics Incorporated
MENLO PARK, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) (“Corcept”) a commercial-stage company engaged in the discovery and development of drugs to...
Corcept Therapeutics Announces Third Quarter Financial Results And Provides Corporate Update
November 03, 2021 16:05 ET
|
Corcept Therapeutics Incorporated
MENLO PARK, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe...
Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call
October 27, 2021 16:05 ET
|
Corcept Therapeutics Incorporated
MENLO PARK, Calif., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report third quarter financial results and provide a corporate update...